Aducanumab and the Medicalization (Still) of Alzheimer's Disease: A Challenge to Measure and Act On What Matters

J Gerontol Nurs. 2021 Sep;47(9):2-4. doi: 10.3928/00989134-20210806-01. Epub 2021 Sep 1.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Alzheimer Disease* / drug therapy
  • Antibodies, Monoclonal, Humanized
  • Humans
  • Medicalization

Substances

  • Antibodies, Monoclonal, Humanized
  • aducanumab